Loading…
Loading…
KFFLF does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for KFFLF and 80,000+ other tickers.
See exactly how KFFLF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for KFFLF and 80,000+ other tickers.
KEFI Gold & Copper Plc engages in mineral exploration and development of mineral deposits. It also explores gold and copper, as well as other precious and base metal deposits. It operates through the following geographical segments: Cyprus, Turkey, Bulgaria, and Ethiopia. The company was founded on October 24, 2006 and is headquartered in Nicosia, Cyprus.
KEFI Gold and Copper Plc (KFFLF) Discusses Share Issuance Impact and Tulu Kapi Project Development Progress Transcript
KEFI Gold and Copper PLC (AIM:KEFI, OTC:KFFLF, FRA:KMSA) shares traded at 1.3p, down 7%, after it completed a £34 million placing priced at 1.2p a share, capping a fast-moving fundraise launched after market close on 19 March and pitched as the final equity piece needed to fully fund development of the Tulu Kapi gold project in Ethiopia. At the same time, it is The placing was described as oversubscribed, and involved existing and new investors.
KEFI Gold and Copper PLC (AIM:KEFI, OTC:KFFLF, FRA:KMSA) shares traded at 1.3p, down 7%, after it completed a £34 million placing priced at 1.2p a share,...
FedEx Corp (NYSE:FDX, XETRA:FDX)’s planned investment in InPost announced this week could help lower European delivery costs and sharpen the company’s focus...
Double-digit earnings outlook and strong trial momentum support top pick status AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) remains a top pick at Citi following...